Sulzer strengthens Tutogen link for $30 million:
This article was originally published in Clinica
Sulzer Medica plans to buy up to 50% of the interests of beneficiaries in Capital Partners II Liquidating Trust, which in turn owns over 50% of Tutogen Medical, for around $30 million. Winterthur, Switzerland-based Sulzer Medica already has a 10% share in Tutogen, which processes bone tissue into bioimplants. Earlier this year, Sulzer bought the rights to Tutogen's Tutoplast human bone tissue products for spinal applications (see Clinica No 899, p 12).